These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34189169)
1. Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d'Ivoire Modeling Analysis. Neilan AM; Cohn J; Sacks E; Gandhi AR; Fassinou P; Walensky RP; Kouadio MN; Freedberg KA; Ciaranello AL Open Forum Infect Dis; 2021 Jun; 8(6):ofab225. PubMed ID: 34189169 [TBL] [Abstract][Full Text] [Related]
2. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis. Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817 [TBL] [Abstract][Full Text] [Related]
3. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis. Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009 [TBL] [Abstract][Full Text] [Related]
5. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Frank SC; Cohn J; Dunning L; Sacks E; Walensky RP; Mukherjee S; Dugdale CM; Turunga E; Freedberg KA; Ciaranello AL Lancet HIV; 2019 Mar; 6(3):e182-e190. PubMed ID: 30737187 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study. Alba C; Malhotra S; Horsfall S; Barnhart ME; Bekker A; Chapman K; Cunningham CK; Fast PE; Fouda GG; Freedberg KA; Goga A; Ghazaryan LR; Leroy V; Mann C; McCluskey MM; McFarland EJ; Muturi-Kioi V; Permar SR; Shapiro R; Sok D; Stranix-Chibanda L; Weinstein MC; Ciaranello AL; Dugdale CM medRxiv; 2023 Nov; ():. PubMed ID: 37986879 [TBL] [Abstract][Full Text] [Related]
7. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis. McCann NC; Cohn J; Flanagan C; Sacks E; Mukherjee S; Walensky RP; Adetunji O; Maeka KK; Panella C; Chadambuka A; Mafaune H; Odhiambo C; Freedberg KA; Ciaranello AL J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1(1):S12-S21. PubMed ID: 32520910 [TBL] [Abstract][Full Text] [Related]
8. Use of Point-of-Care Nucleic Acid Tests Beyond Early Infant Diagnosis of HIV: A Retrospective Case Review in Lesotho. Macneal K; Tukei V; Sacks E; Mokone M; Makoti L; Tumbare E; Samosamo T; Mots'oane T; Lemaire JF; Cohn J J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1():S78-S83. PubMed ID: 32520919 [TBL] [Abstract][Full Text] [Related]
9. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less. Ochodo EA; Guleid F; Deeks JJ; Mallett S Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013207. PubMed ID: 34383961 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age. Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies. le Roux SM; Odayar J; Sutcliffe CG; Salvatore PP; de Broucker G; Dowdy D; McCann NC; Frank SC; Ciaranello AL; Myer L; Vojnov L Lancet HIV; 2023 May; 10(5):e320-e331. PubMed ID: 37149292 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire. Ouattara EN; Ross EL; Yazdanpanah Y; Wong AY; Robine M; Losina E; Moh R; Walensky RP; Danel C; Paltiel AD; Eholié SP; Freedberg KA; Anglaret X J Acquir Immune Defic Syndr; 2014 Jul; 66(3):294-302. PubMed ID: 24732870 [TBL] [Abstract][Full Text] [Related]
13. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348 [TBL] [Abstract][Full Text] [Related]
14. Passive surveillance of human African trypanosomiasis in Côte d'Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. Koné M; Kaba D; Kaboré J; Thomas LF; Falzon LC; Koffi M; Kouamé CM; Ahouty B; Compaoré CFA; N'Gouan EK; Solano P; Fèvre E; Büscher P; Lejon V; Jamonneau V PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009656. PubMed ID: 34460829 [TBL] [Abstract][Full Text] [Related]
15. Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector. Lee DJ; Kumarasamy N; Resch SC; Sivaramakrishnan GN; Mayer KH; Tripathy S; Paltiel AD; Freedberg KA; Reddy KP PLoS One; 2019; 14(7):e0218890. PubMed ID: 31265470 [TBL] [Abstract][Full Text] [Related]
16. Willingness to use a rapid diagnostic test for malaria in a rural area of central Côte d'Ivoire. Comoé CC; Ouattara AF; Raso G; Tanner M; Utzinger J; Koudou BG BMC Public Health; 2012 Dec; 12():1089. PubMed ID: 23249239 [TBL] [Abstract][Full Text] [Related]
17. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa. Duchesne L; Hejblum G; Njouom R; Touré Kane C; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K PLoS One; 2020; 15(8):e0238035. PubMed ID: 32833976 [TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa. Boyer S; Baudoin M; Nishimwe ML; Santos M; Lemoine M; Maradan G; Sylla B; Kouanfack C; Carrieri P; Mourad A; Rouveau N; Moh R; Seydi M; Attia A; Woode ME; Lacombe K BMC Health Serv Res; 2022 Mar; 22(1):303. PubMed ID: 35248039 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes. McCann NC; Stanic T; Penazzato M; Flanagan CF; Abrams EJ; Dugdale CM; Johnson LF; Neilan AM; Davies MA; Freedberg KA; Fassinou P; Doherty M; Essajee S; Mushavi A; Soeteman DI; Ciaranello AL J Int AIDS Soc; 2022 Dec; 25(12):e26045. PubMed ID: 36519674 [TBL] [Abstract][Full Text] [Related]
20. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis. Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA; AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]